Alio plans to increase the use case for its wearable remote monitoring SmartPatch technology to monitor health metrics in dialysis patients without vascular accesss...
Building on long-term data announced earlier this year, CVRx has reported durable improvements in heart failure patients with its Barostim device over 24 months.
The...
iRhythm Technologies announced initial research findings on its Zio monitor’s post-market, real-world performance. The company presented the data on its next-generation long-term continuous monitoring...
ExThera Medical’s OSCAR I Study (ONCObind CTC Removal Study), aimed at treating Metastatic Pancreatic Ductal Adenocarcinoma (PDAC), has enrolled the first patient at OU...
Median Technologies has announced that eyonis LCS, its proprietary AI/machine learning powered Software as a Medical Device (SaMD) for lung cancer screening (LCS), met...
Swedish medical detection company SciBase Holding has seen its artificial intelligence (AI) powered device for detecting melanomas, dubbed Nevisense, validated as part of a...
Another site has enrolled its first patient in RenovoRx’s Phase III trial evaluating a drug-device combination therapy to treat locally advanced pancreatic cancer.
The latest...
California-based diagnostic imaging firm, Invenio Imaging, has announced that it has completed enrolment for a pivotal trial of its artificial intelligence (AI) driven software...
PhotoPharmics has enrolled the first 100 subjects in its clinical trial investigating a light therapy device designed for the treatment of Parkinson’s disease (PD).
The...